AAAAAA
Results:
1-14
|
Results: 14
Authors:
Malkowicz, SB
McKenna, WG
Vaughn, DJ
Wan, XS
Propert, KJ
Rockwell, K
Marks, SHF
Wein, AJ
Kennedy, AR
Citation: Sb. Malkowicz et al., Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia, PROSTATE, 48(1), 2001, pp. 16-28
Authors:
Wan, XS
Huang, TY
Citation: Xs. Wan et Ty. Huang, The orbit evolution of 32 plutinos over 100 million year, ASTRON ASTR, 368(2), 2001, pp. 700-705
Authors:
Wan, XS
Huang, TY
Innanen, KA
Citation: Xs. Wan et al., The 1 : 1 superresonance in Plutois motion, ASTRONOM J, 121(2), 2001, pp. 1155-1162
Authors:
Armstrong, WB
Kennedy, AR
Wan, XS
Taylor, TH
Nguyen, QA
Jensen, J
Thompson, W
Lagerberg, W
Meyskens, FL
Citation: Wb. Armstrong et al., Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial, CLIN CANC R, 6(12), 2000, pp. 4684-4691
Authors:
Wan, XS
Qin, W
Ling, XT
Citation: Xs. Wan et al., Cascaded parallel oversampling sigma-delta modulators, IEEE CIR-II, 47(2), 2000, pp. 156-161
Authors:
Wan, XS
Lu, LJW
Anderson, KE
Ware, JH
Kennedy, AR
Citation: Xs. Wan et al., Urinary excretion of Bowman-Birk inhibitor in humans after soy consumptionas determined by a monoclonal antibody-based immunoassay, CANC EPID B, 9(7), 2000, pp. 741-747
Authors:
Armstrong, WB
Kennedy, AR
Wan, XS
Atiba, J
McLaren, E
Meyskens, FL
Citation: Wb. Armstrong et al., Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia, CANC EPID B, 9(1), 2000, pp. 43-47
Authors:
Wan, XS
Meyskens, FL
Armstrong, WB
Taylor, TH
Kennedy, AR
Citation: Xs. Wan et al., Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor, CANC EPID B, 8(7), 1999, pp. 601-608
Authors:
Xu, Y
Krishnan, A
Wan, XS
Majima, H
Yeh, CC
Ludewig, G
Kasarskis, EJ
St Clair, DK
Citation: Y. Xu et al., Mutations in the promoter reveal a cause for the reduced expression of thehuman manganese superoxide dismutase gene in cancer cells, ONCOGENE, 18(1), 1999, pp. 93-102
Authors:
Wan, XS
Ware, JH
Zhang, LL
Newberne, PM
Evans, SM
Clark, LC
Kennedy, AR
Citation: Xs. Wan et al., Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice, PROSTATE, 41(4), 1999, pp. 243-252
Authors:
Zhang, LL
Wan, XS
Donahue, JJ
Ware, JH
Kennedy, AR
Citation: Ll. Zhang et al., Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin-or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells, NUTR CANCER, 33(2), 1999, pp. 165-173
Authors:
Ware, JH
Wan, XS
Kennedy, AR
Citation: Jh. Ware et al., Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells, NUTR CANCER, 33(2), 1999, pp. 174-177
Authors:
Ware, JH
Wan, XS
Newberne, P
Kennedy, AR
Citation: Jh. Ware et al., Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis, DIG DIS SCI, 44(5), 1999, pp. 986-990
Authors:
Yeh, CC
Wan, XS
St Clair, DK
Citation: Cc. Yeh et al., Transcriptional regulation of the 5 ' proximal promoter of the human manganese superoxide dismutase gene, DNA CELL B, 17(11), 1998, pp. 921-930
Risultati:
1-14
|